Active Ingredient: VORASIDENIB
Proprietary Name: VORANIGO
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 40MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N218784
Product Number: 002
Approval Date: Aug 6, 2024
Applicant Holder Full Name: SERVIER PHARMACEUTICALS LLC
Marketing Status:
Prescription
Patent and Exclusivity Information
